These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGH
1151 results:

  • 1. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM
    Methods Mol Biol; 2025; 2865():189-219. PubMed ID: 39424725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression Cloning of Antibodies from Single Human B Cells.
    Rollenske T; Murugan R; Wardemann H; Busse CE
    Methods Mol Biol; 2025; 2865():103-124. PubMed ID: 39424722
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.
    Zhang X; Yang L; Zhu M; Zhao X; Xiao Y; Pang J; Zhu L; Ou Q; Ni HW; Xu J
    Future Oncol; 2024; 20(38):3107-3117. PubMed ID: 39417339
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Imatinib mesylate reduces c-MYC expression in double-hit lymphoma cells by suppressing inducible cytidine deaminase.
    Zhang J; Zhou S; Jiang S; He F; Tu Y; Hu H
    J Cancer Res Clin Oncol; 2024 Sep; 150(9):426. PubMed ID: 39299959
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report.
    Zhang J; Ma J; Li Y; Lv X; Feng L
    Cancer Biol Ther; 2024 Dec; 25(1):2403203. PubMed ID: 39295116
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement.
    Elbaz Younes I; Bunting ST; Zhang X
    Int J Hematol; 2024 Dec; 120(6):750-754. PubMed ID: 39285033
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials.
    Khouja M; Jiang L; Pal K; Stewart PJ; Regmi B; Schwarz M; Klapper W; Alig SK; Darzentas N; Kluin-Nelemans HC; Hermine O; Dreyling M; Gonzalez de Castro D; Hoster E; Pott C;
    Leukemia; 2024 Dec; 38(12):2675-2684. PubMed ID: 39284897
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Non-canonical
    Langabeer SE
    Oncol Res; 2024; 32(9):1423-1427. PubMed ID: 39220131
    [TBL] [Abstract] [Full Text] [Related]  

  • 9.
    Moreno-Lorenzana D; Juárez-Velázquez R; Reyes-León A; Martínez-Anaya D; Juárez-Villegas L; Zapata Tarrés M; López Santiago N; Pérez-Vera P
    Leuk Lymphoma; 2024 Dec; 65(12):1853-1863. PubMed ID: 39034479
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Laboratory validation and clinical utility of next-generation sequencing-based igh/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology.
    Ma SB; Lin W; Campbell J; Clerici K; White D; Yeung D; Gorniak M; Fleming S; Fong CY; Agarwal R
    Pathology; 2024 Dec; 56(7):982-992. PubMed ID: 39025724
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma.
    Cirrincione AM; Poos AM; Ziccheddu B; Kaddoura M; Bärtsch MA; Maclachlan K; Chojnacka M; Diamond B; John L; Reichert P; Huhn S; Blaney P; Gagler D; Rippe K; Zhang Y; Dogan A; Lesokhin AM; Davies F; Goldschmidt H; Fenk R; Weisel KC; Mai EK; Korde N; Morgan GJ; Usmani S; Landgren O; Raab MS; Weinhold N; Maura F
    Blood; 2024 Aug; 144(7):771-783. PubMed ID: 38728430
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clonotypic VDJ Rearrangements in Mixed Phenotype Acute leukemia can be Successfully Utilized to Track Minimal Residual Disease.
    Hennawi M; Quadeer F; Pakasticali N; Osman S; Tashkandi H; Hussaini MO
    Appl Immunohistochem Mol Morphol; 2024 Aug; 32(7):305-308. PubMed ID: 38695552
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IKZF1
    Kovach AE; Wengyn M; Vu MH; Doan A; Raca G; Bhojwani D
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30996. PubMed ID: 38637852
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy.
    Vervoordeldonk MYL; Hengeveld PJ; Levin MD; Langerak AW
    Leuk Lymphoma; 2024 Aug; 65(8):1031-1043. PubMed ID: 38619476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Two recurrent types of
    Maekawa F; Hayashida M; Takeoka K; Fukutsuka K; Nakagawa M; Akasaka T; Sakamoto S; Sumiyoshi S; Kobashi Y; Ohno H
    Leuk Lymphoma; 2024 Aug; 65(8):1100-1109. PubMed ID: 38608254
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diverse B-cell tumors associated with t(14;19)(q32;q13)/igh::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
    Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
    J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
    Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
    Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation.
    Garimberti E; Federico C; Ragusa D; Bruno F; Saccone S; Bridger JM; Tosi S
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397052
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic Factors in Philadelphia Chromosome-Positive Acute Myeloid leukemia Using Fluorescence in Situ Hybridization.
    Zhang Z; Sun C; Cai L; Chen Y; Zhou X; Chen S; Feng X; Yang X; Li Q; Liu L; Zhou H; Li B
    Clin Lab; 2024 Feb; 70(2):. PubMed ID: 38345995
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 58.